BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao Z, Zhong X, Tan YX, Liu D. Apelin‑13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis. Int J Mol Med 2021;48:175. [PMID: 34278446 DOI: 10.3892/ijmm.2021.5008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 İçen G, Dağlıoğlu G, Evran M. Evaluation of Apelin-13 levels in patients with diabetic nephropathy. Int Urol Nephrol 2023;55:345-53. [PMID: 35925488 DOI: 10.1007/s11255-022-03323-0] [Reference Citation Analysis]
2 Huang W, Chen YY, Li ZQ, He FF, Zhang C. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases. Int J Mol Sci 2022;23:10882. [PMID: 36142794 DOI: 10.3390/ijms231810882] [Reference Citation Analysis]
3 Li C, Cheng H, Adhikari BK, Wang S, Yang N, Liu W, Sun J, Wang Y. The Role of Apelin–APJ System in Diabetes and Obesity. Front Endocrinol 2022;13:820002. [DOI: 10.3389/fendo.2022.820002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Li S, Wang D, Zhang M, Zhang C, Piao F. Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-93337-1_22] [Reference Citation Analysis]
5 de Oliveira AA, Vergara A, Wang X, Vederas JC, Oudit GY. Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists. Peptides 2021;147:170697. [PMID: 34801627 DOI: 10.1016/j.peptides.2021.170697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]